Clinical Evidence: How Does Wegovy Work vs Mounjaro?
Does Wegovy Work Through a Different Mechanism Than Mounjaro?
Understanding how Wegovy works compared to Mounjaro begins with their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. Mounjaro (tirzepatide) works differently as a dual GIP and GLP-1 receptor agonist, targeting two hormone pathways simultaneously. Both treatments are designed to be used alongside a reduced-calorie diet and increased physical activity.
The question "does Wegovy work as effectively" depends partly on these mechanistic differences. Wegovy's single-pathway approach has been extensively studied in the STEP clinical trial programme, whilst Mounjaro's dual-pathway mechanism represents a newer therapeutic approach. Your prescriber can evaluate which mechanism may be more suitable based on your individual medical history, current medications, and weight management goals during the clinical assessment process.
Wegovy vs Mounjaro Pricing: Does Wegovy Work Out More Cost-Effective?
Cost considerations often influence whether Wegovy works within your budget compared to Mounjaro. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (weeks 1-4) with new customer code FIRST40 applied at checkout, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing your first two months of treatment with convenient single-order processing.
Mounjaro follows a different pricing structure reflecting its 6-dose escalation schedule versus Wegovy's 5-dose approach. Both treatments require prescription-only medicine oversight from our GPhC-registered clinical team (#9012878), ensuring appropriate monitoring throughout dose titration. Returning customers can use code DOSE25 for ongoing orders, making long-term treatment planning more predictable. The practical question of whether Wegovy works better value-wise depends on your individual dose requirements and treatment duration.
Clinical Evidence: Does Wegovy Work According to Published Trials?
The landmark STEP 1 trial provides robust evidence for how Wegovy works in clinical practice. In this study by Wilding et al., published in the New England Journal of Medicine (2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The STEP 5 trial demonstrated that this effect can be sustained, with participants maintaining approximately clinically studied weight loss at 2 years of continuous treatment.
Additional evidence comes from the SELECT cardiovascular outcomes trial, showing a 20% reduction in major cardiovascular events (hazard ratio 0.80) in patients using semaglutide. This cardiovascular benefit answers whether Wegovy works beyond weight management alone, suggesting broader metabolic health improvements. NICE TA875 recommends Wegovy with specialist weight management support, confirming its clinical value within the UK healthcare system.
Mechanism Explained: How Does Wegovy Work at the Cellular Level?
Wegovy works by mimicking glucagon-like peptide-1 (GLP-1), a hormone naturally produced in your intestines after eating. This synthetic version binds to GLP-1 receptors in your brain's appetite control centres, specifically the hypothalamus, reducing hunger signals and increasing feelings of fullness. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Unlike stimulant-based appetite suppressants, Wegovy works through your body's existing hormone pathways, which may explain its sustained effectiveness in clinical trials. The once-weekly injection schedule maintains consistent hormone levels, supporting steady appetite regulation throughout your weight management programme.
Ordering Process: How Does Wegovy Work Within Our Service Model?
Our streamlined ordering process demonstrates how Wegovy works within a comprehensive pharmaceutical care model. The initial 3-minute online clinical assessment captures your medical history, current medications, and weight management goals, enabling our prescribers to evaluate suitability for either Wegovy or Mounjaro. Standard prescriber review takes 3 working days, with express 24-hour review available for urgent requirements. Once approved, next-day delivery ensures temperature-controlled cold-chain transport, maintaining medication integrity from our GPhC-registered facility to your door. This integrated approach addresses the practical question of how Wegovy works within busy lifestyles, minimising disruption whilst maintaining clinical oversight throughout your treatment journey.
Storage and Practical Considerations: Does Wegovy Work More Conveniently?
Wegovy's storage requirements may influence whether it works practically for your lifestyle compared to Mounjaro. Wegovy maintains stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage becomes significant for frequent travellers or those with limited refrigeration access. The FlexTouch pen design provides consistent, accurate dosing with minimal preparation required. Dose escalation follows a structured schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards, with mandatory progression through each stage to optimise tolerability.
Wegovy vs Mounjaro: Does Wegovy Work Better for Specific Patient Groups?
The question "does Wegovy work better than Mounjaro" lacks a universal answer, as both treatments serve different patient needs. Wegovy's established clinical evidence base and longer market presence provide extensive real-world safety data, which may suit patients preferring well-established treatments. The single GLP-1 pathway may also result in different side effect profiles compared to Mounjaro's dual-hormone approach.
Mounjaro's newer dual-mechanism offers potential advantages for patients who haven't achieved optimal results with GLP-1-only treatments previously. However, this newer approach means less long-term safety data compared to Wegovy's extensive clinical experience. Your prescriber evaluates these factors alongside your medical history, previous treatment responses, and individual risk factors to determine which option may work most effectively for your circumstances.
Making Your Decision: Does Wegovy Work for Long-Term Weight Management?
Long-term effectiveness remains crucial when evaluating whether Wegovy works for sustained weight management. The STEP 1 extension study revealed that patients regained approximately two-thirds of lost weight within one year of stopping treatment, highlighting that weight management represents a long-term commitment rather than a short-term intervention. This evidence supports viewing Wegovy as part of an ongoing lifestyle modification programme rather than a temporary solution. Both Wegovy and Mounjaro are available through EverydayMeds, ensuring continuity of care regardless of which treatment your prescriber recommends. Our clinical team provides ongoing monitoring and dose adjustment guidance, supporting optimal outcomes throughout your weight management journey with either prescription-only medicine option.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
